Bmi-1 overexpression has been reported in a plethora of cancers, including gastric, ovarian, breast, head and neck, pancreatic, lung, hepatocellular, and endometrial carcinoma and correlated with a variety of indicators of poor prognoses as described elsewhere (82). This evidence concerns the gene BMI1 and cancer.